Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Gastrointest Endosc. 2012 Jun;75(6):1159-65. doi: 10.1016/j.gie.2012.02.015. Epub 2012 Apr 5.
Perforation is a common complication of endoscopic submucosal dissection (ESD), but little is known about the relevant risk factors.
To investigate the risk factors for perforation.
Retrospective study.
A cancer referral center.
A total of 1795 early gastric tumors in 1500 patients treated by ESD from July 2002 to December 2010 were included in the analysis.
The associations between the incidence of perforation and patient and lesion characteristics were investigated.
Perforation during ESD occurred in 50 lesions (2.8%). Univariate analysis identified tumor location (upper, middle, or lower stomach), tumor diameter (≤ 20 or >20 mm), and treatment period (lesions treated in the first or second period) as predictors of perforation. Multivariate analysis identified tumor location (upper stomach), tumor diameter (>20 mm), and treatment period (first half) as independent risk factors for perforation. The odds ratios were 2.4 (95% CI, 1.3-4.7; P = .006) for lesions in the upper stomach and 1.9 (95% CI, 1.0-3.5; P = .04) for lesions larger than 20 mm. Perforation risks were 5.4% for lesions in the upper stomach and 4.4% for lesions larger than 20 mm. Three patients required emergency surgery, but the rest of the patients were successfully treated with endoscopic clipping. There was no perforation-related mortality.
Single-center, retrospective study design.
Lesions in the upper stomach and lesions larger than 20 mm were independent risk factors for perforation during ESD. Patients should be made aware of the estimated high risks of these lesions before undergoing ESD.
内镜黏膜下剥离术(ESD)后穿孔是一种常见的并发症,但对于相关的危险因素知之甚少。
探讨穿孔的危险因素。
回顾性研究。
癌症转诊中心。
共纳入 1500 例患者的 1795 个早期胃肿瘤,这些患者于 2002 年 7 月至 2010 年 12 月接受 ESD 治疗。
分析穿孔的发生率与患者和病变特征之间的关系。
ESD 过程中发生穿孔 50 例(2.8%)。单因素分析确定肿瘤位置(上、中、下胃)、肿瘤直径(≤20 或>20mm)和治疗期(第 1 期或第 2 期治疗的病变)为穿孔的预测因素。多因素分析确定肿瘤位置(上胃)、肿瘤直径(>20mm)和治疗期(前半部分)为穿孔的独立危险因素。比值比(OR)分别为上胃病变的 2.4(95%可信区间,1.3-4.7;P=0.006)和>20mm 病变的 1.9(95%可信区间,1.0-3.5;P=0.04)。上胃病变穿孔风险为 5.4%,>20mm 病变穿孔风险为 4.4%。3 例患者需要紧急手术,但其余患者均成功采用内镜夹闭治疗。无穿孔相关死亡病例。
单中心、回顾性研究设计。
上胃病变和>20mm 病变是 ESD 穿孔的独立危险因素。在接受 ESD 治疗前,应让患者了解这些病变穿孔的风险估计值较高。